INTRACORONARY STEM CELL THERAPY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION - 36 MONTHS RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL WITH SERIAL MRI FOLLOW-UPS

Conclusions In this rigorous double-blind, randomized, placebo-controlled trial we did not observe an evidence for a positive effect for intracoronary BMC as compared to placebo therapy with respect to LVEF, LV volume indices and infarct size determined by six serial CMRI studies within a 36 months...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2012-03, Vol.59 (13), p.E346
Main Authors: Woehrle, Jochen, von Scheidt, Fabian, Markovic, Sinisa, Schauwecker, Peter, Schwarz, Klaus, Wiesneth, Markus, Schrezenmeier, Hubert, Hombach, Vinzenz, Rottbauer, Wolfgang, Bernhardt, Peter
Format: Article
Language:English
Subjects:
Cardiology
Heart attacks
Medical research
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Conclusions In this rigorous double-blind, randomized, placebo-controlled trial we did not observe an evidence for a positive effect for intracoronary BMC as compared to placebo therapy with respect to LVEF, LV volume indices and infarct size determined by six serial CMRI studies within a 36 months period.
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(12)60347-7